- Home
- KMDA vs IGD Comparison
KMDA vs IGD Comparison
Compare KMDA & IGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- IGD
- Stock Information
- Founded
- KMDA 1990
- IGD N/A
- Country
- KMDA Israel
- IGD United States
- Employees
- KMDA N/A
- IGD N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- IGD Trusts Except Educational Religious and Charitable
- Sector
- KMDA Health Care
- IGD Finance
- Exchange
- KMDA Nasdaq
- IGD Nasdaq
- Market Cap
- KMDA 442.1M
- IGD 432.2M
- IPO Year
- KMDA N/A
- IGD N/A
- Fundamental
- Price
- KMDA $7.46
- IGD $5.51
- Analyst Decision
- KMDA Strong Buy
- IGD
- Analyst Count
- KMDA 2
- IGD 0
- Target Price
- KMDA $14.50
- IGD N/A
- AVG Volume (30 Days)
- KMDA 346.0K
- IGD 215.3K
- Earning Date
- KMDA 03-05-2025
- IGD 01-01-0001
- Dividend Yield
- KMDA N/A
- IGD 9.15%
- EPS Growth
- KMDA 124.29
- IGD N/A
- EPS
- KMDA 0.27
- IGD N/A
- Revenue
- KMDA $158,380,000.00
- IGD N/A
- Revenue This Year
- KMDA $15.37
- IGD N/A
- Revenue Next Year
- KMDA $8.58
- IGD N/A
- P/E Ratio
- KMDA $28.13
- IGD N/A
- Revenue Growth
- KMDA 4.52
- IGD N/A
- 52 Week Low
- KMDA $4.74
- IGD $4.60
- 52 Week High
- KMDA $9.15
- IGD $5.26
- Technical
- Relative Strength Index (RSI)
- KMDA 52.89
- IGD 55.46
- Support Level
- KMDA $7.51
- IGD $5.31
- Resistance Level
- KMDA $8.35
- IGD $5.47
- Average True Range (ATR)
- KMDA 0.41
- IGD 0.05
- MACD
- KMDA -0.02
- IGD 0.01
- Stochastic Oscillator
- KMDA 33.20
- IGD 88.64
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.